| |
|
|
Session 115
Poster Presentations Determinants of Disease Progression and Mortality Tuesday 1:30 - 3:30 pm Hall B |
| 907 | Relationship Between HIV-1 Viral Subtype, Disease Progression, and Response to Antiretroviral Therapy P. J. Easterbrook*1, M. Smith1, J. Mullen3, S. OShea3, A. M. Geretti1, S. Murad1, I. Chrystie3, A. M. de Ruiter3, M. Mvere1, B. Kulasegaram3, M. Zuckerman1, The Guys, Kings, and St. Thomas HIV Collaborative Group1 1King's Coll, London, UK and 3St Thomas' Hosp, London, UK |
| 908 | Determinants of HIV Viral Load in Incident and Prevalent Infections, Rakai, Uganda R. H. Hray*1, M. J. Wawer2, X. Li1, D. Serwadda3, N. Sewankambo3, T. Lutalo4, N. Kiwanuka5, G. Kigozi5, F. Wabwire-Mangen3, T. Quinn1 1Johns Hopkins Univ, Baltimore, MD; 2Columbia University, New York, NY; 3Makerere Univ, Kamplala, Uganda; 4Uganda Virus Res Inst, Entebbe; and 5Rakai Project, Entebbe, Uganda |
| 909 | Modelling the Variation of CD4 Cell Count Depending on Virologic Suppression in HIV-infected Patients Receiving Antiretroviral Therapy I. Kousignian*1, S. Abgrall1, X. Duval2, V. Joly2, D. Descamps2, S. Matheron2, D. Costagliola1, The Clinical Epidemiology Group from the French Hospital Database on HIV3 1INSERM EMI 0214, Paris, France; 2Hosp Bichat-Claude Bernard, Paris, France; and 3France |
| 910 | Progression to AIDS/Death is Higher in Patients Initiating Antiretroviral Therapy with CD4 Counts below 350 Cells/µL E. Ferrer*, E. Santamarina, M. Santin, B. Roson, M. J. Barbera, E. Fumero, J. Niubo, D. Podzamczer Hosp de Bellvitge, Barcelona, Spain |
| 911 | Rising Mortality Rates among Recent Entrants to Care for HIV Infection W. Mathews*, E. Barber Univ of California at San Diego Med Ctr |
| 912 | Comparison of Rates of Death Due to HIV Disease among U.S. Hispanics of Different National Origins in 2000 R. Selik* CDC, Atlanta, GA |
| 913 | Characteristics and Causes of Death Among HIV-infected Patients Who had a Good Immunovirologic Response under HAART: French National Survey "Mortalité 2000" T. MAY*1, C. LEWDEN2, F. BONNET3, L. HERIPRET4, S. BEVILACQUA1, E. JOUGLA5, P. MORLAT3, G. CHENE2, D. SALMON4, Mortality Study Group 1CHU Nancy, France; 2INSERM U330, Bordeaux, France; 3CHU Bordeaux; 4CHU Cochin, Paris, France; and 5CépiDC Le Vésinet |
| 914 | HIV Patients have More Thromboembolic Events than Controls Which are Associated with Poorer Survival S. L. Fultz*1,2, A. C. Justice1,2, K. A. McGinnis1, M. Skanderson1, M. V. Ragni2,3 1Veterans Admin Pittsburgh Hlthcare Sys, PA; 2Univ of Pittsburgh Sch of Med, PA; and 3Hemophilia Ctr of Western Pennsylvania, Pittsburgh, PA |
| 915 | The High Cost of Providing Medical Care to Patients Who Present Late (<100/mm3) with HIV Infection M. J. Gill*, H. B. Krentz, C. M. Auld Univ of Calgary, Canada |
| 916 | Assessing Health-related Quality of Life in Routine Clinical Care of HIV-infected Patients H. Crane*, A. Young, M. Kitahata Univ of Washington, Seattle |
| 917 | HIV-related Health Beliefs, Attitudes, and Adherence of Inmates in a Directly Observed Treatment Setting B. L. Stephenson*1, D. Wohl1, R. D. Hays2, C. E. Golin1, H. Liu2, G. Simpson1, A. H. Kaplan1, N. Kiziah3 1Univ of North Carolina, Chapel Hill; 2Univ of California at Los Angeles; and 3North Carolina Department of Corrections |
| 917a | Closing the Gap: Death Rates in the Swiss HIV Cohort Study (SHCS) Compared to the Swiss Reference Population C. Jaggy1, B. Ledergerber2, J. von Overbeck1, C. Schwarz1, S. Baumgartner3, M. Rickenbach4, H. Furrer5, A. Telenti6, M. Battegay7, M. Flepp2, P. Vernazza8, E. Bernasconi9, B. Hirschel*10, Swiss HIV Cohort Study 1SwissRe, Zurich; 2Univ Hosp, Zurich; 3Swiss Federal Office of Statistics, Neuchâtel; 4Swiss HIV Cohort Study, Lausanne; 5Univ Hosp, Bern; 6CHUV, Lausanne; 7Univ Hosp, Basel; 8Kantonsspital St Gallen; 9Ospedale civico, Lugano; and 10Univ Hosp, Geneva |